ISPOR ANNOUNCES 2016-2017 BOARD OF DIRECTORS

Published Jul 5, 2016
Princeton, NJ—July 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the election of the Society’s 2016-2017 Board of Directors that assumed office on July 1, 2016. ISPOR’s Board of Directors are elected by its global membership. Lou Garrison, PhD assumes the role of President for 2016-17 after most recently serving as the Society’s President-Elect. Dr. Garrison is Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington in Seattle, WA, USA. Shelby D. Reed, RPh, PhD was elected to serve as President-Elect for the Society for 2016-17. Dr. Reed is Professor, Duke University in Durham, NC, USA. The following were elected as ISPOR Board Members for 2016-18: - Joanna Lis, MSc, MBA, PhD, Director of Market Access, Sanofi-Aventis (Warsaw, Poland) - Gordon Liu, PhD, PKU Yangtze River Scholar Professor of Economics, Peking University National School of Development, Director, PKU China Center for Health Economic Research (Beijing, China) - Rosanna Tarricone, MSc, PhD, Associate Professor, Bocconi University (Milan, Italy) - John Watkins, MPH, PharmD, Formulary Manager, Premera Blue Cross (Mountlake Terrace, WA, USA) Returning Board members include: Past President: - Daniel C. Malone, RPh, PhD, Professor of Pharmacy, College of Pharmacy and Associate Professor in Mel and Enid Zuckerman College, University of Arizona (Tucson, AZ, USA)  Treasurer: - Zeba M. Khan, RPh, PhD, Vice President, Celgene Corporation (Summit, NJ, USA) CEO and Executive Director: - Nancy S. Berg, CEO and Executive Director, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (Lawrenceville, NJ, USA) Directors: - Nancy Devlin, PhD, Director of Research, Office of Health Economics (London, UK) - Manuel Espinoza, MD, MSc, PhD, Professor, Department of Public Health and Chief, HTA Unit, Catholic University of Chile (Santiago, Chile) and Honorary Visiting Fellow, Centre for Health Economics University of York (York, UK) - Dana Goldman, PhD, Leonard D. Schaeffer Director's Chair and Director, Schaeffer Center for Health Policy and Economics, University of Southern California (Los Angeles, CA, USA)

###

Related Stories

ISPOR 2026 Plenaries and Speakers Announced

Apr 8, 2026

ISPOR announced the plenary sessions and speakers for ISPOR 2026, its annual international conference, and the leading global conference for health economics and outcomes research (HEOR). ISPOR 2026 will be held May 17-20 in Philadelphia, PA. The conference convenes nearly 5000 healthcare stakeholders from around the world to discuss topical issues in the field. The content theme for ISPOR 2026 is, “HEOR at the Forefront of Policy, Access, and Value.”

ISPOR Publishes Recommendations on Valuing Child and Adolescent Health for Economic Evaluations

Apr 7, 2026

Value in Health, the official journal of ISPOR announced the publication of an ISPOR Good Practices Report providing first-of-its-kind international guidance on quantifying the value of health outcomes in children. The report, “Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force,” was published in the April 2026 issue of Value in Health.

Progress and Paradox: Healthcare Reform, Innovation, and Inequality in the Arabian Gulf and Wider Region

Apr 1, 2026

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that presents a comprehensive body of evidence aimed at advancing value-based healthcare across the Arabian Gulf and the wider Middle East and North Africa region. Guest editors for the themed section are Paul Revill, Sara Al-Dallal, and Anderson Stanciole. The series was published in the March 2026 issue of Value in Health Regional Issues.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×